Encephalitis Vaccine Market, Global Outlook and Forecast 2022-2028

April 2022 | 70 pages | ID: E13734E31B4BEN
Market Monitor Global

Abstracts

Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds.

This report contains market size and forecasts of Encephalitis Vaccine in global, including the following market information:

Global Encephalitis Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Encephalitis Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Encephalitis Vaccine companies in 2021 (%)

The global Encephalitis Vaccine market was valued at 1186.3 million in 2021 and is projected to reach US$ 1709.7 million by 2028, at a CAGR of 5.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Encephalitis Vaccine include Valneva, Sanofi Pasteur, Biken, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Chengdu Institute of Biological Products, Tiantan Biological Products, Liaoning Chengda and Zhejiang Tianyuan Bio-Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Encephalitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Encephalitis Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Encephalitis Vaccine Market Segment Percentages, by Type, 2021 (%)

• Inactivated Vaccine
• Live Attenuated Vaccine

Global Encephalitis Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Encephalitis Vaccine Market Segment Percentages, by Application, 2021 (%)

• Child
• Adult

Global Encephalitis Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Encephalitis Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Encephalitis Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Encephalitis Vaccine revenues share in global market, 2021 (%)

Key companies Encephalitis Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)

Key companies Encephalitis Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Valneva
• Sanofi Pasteur
• Biken
• Wuhan Institute of Biological Products
• Lanzhou Institute of Biological Products
• Chengdu Institute of Biological Products
• Tiantan Biological Products
• Liaoning Chengda
• Zhejiang Tianyuan Bio-Pharmaceutical
• Yisheng Bio
• Changchun Institute of Biological Products

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Encephalitis Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Encephalitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENCEPHALITIS VACCINE OVERALL MARKET SIZE

2.1 Global Encephalitis Vaccine Market Size: 2021 VS 2028
2.2 Global Encephalitis Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Encephalitis Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Encephalitis Vaccine Players in Global Market
3.2 Top Global Encephalitis Vaccine Companies Ranked by Revenue
3.3 Global Encephalitis Vaccine Revenue by Companies
3.4 Global Encephalitis Vaccine Sales by Companies
3.5 Global Encephalitis Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Encephalitis Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Encephalitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Encephalitis Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Encephalitis Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Encephalitis Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Encephalitis Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Inactivated Vaccine
  4.1.3 Live Attenuated Vaccine
4.2 By Type - Global Encephalitis Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Encephalitis Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Encephalitis Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Encephalitis Vaccine Sales & Forecasts
  4.3.1 By Type - Global Encephalitis Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Encephalitis Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Encephalitis Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Encephalitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Encephalitis Vaccine Market Size, 2021 & 2028
  5.1.2 Child
  5.1.3 Adult
5.2 By Application - Global Encephalitis Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Encephalitis Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Encephalitis Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Encephalitis Vaccine Sales & Forecasts
  5.3.1 By Application - Global Encephalitis Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Encephalitis Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Encephalitis Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Encephalitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Encephalitis Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Encephalitis Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Encephalitis Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Encephalitis Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Encephalitis Vaccine Sales & Forecasts
  6.3.1 By Region - Global Encephalitis Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Encephalitis Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Encephalitis Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Encephalitis Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Encephalitis Vaccine Sales, 2017-2028
  6.4.3 US Encephalitis Vaccine Market Size, 2017-2028
  6.4.4 Canada Encephalitis Vaccine Market Size, 2017-2028
  6.4.5 Mexico Encephalitis Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Encephalitis Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Encephalitis Vaccine Sales, 2017-2028
  6.5.3 Germany Encephalitis Vaccine Market Size, 2017-2028
  6.5.4 France Encephalitis Vaccine Market Size, 2017-2028
  6.5.5 U.K. Encephalitis Vaccine Market Size, 2017-2028
  6.5.6 Italy Encephalitis Vaccine Market Size, 2017-2028
  6.5.7 Russia Encephalitis Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Encephalitis Vaccine Market Size, 2017-2028
  6.5.9 Benelux Encephalitis Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Encephalitis Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Encephalitis Vaccine Sales, 2017-2028
  6.6.3 China Encephalitis Vaccine Market Size, 2017-2028
  6.6.4 Japan Encephalitis Vaccine Market Size, 2017-2028
  6.6.5 South Korea Encephalitis Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Encephalitis Vaccine Market Size, 2017-2028
  6.6.7 India Encephalitis Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Encephalitis Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Encephalitis Vaccine Sales, 2017-2028
  6.7.3 Brazil Encephalitis Vaccine Market Size, 2017-2028
  6.7.4 Argentina Encephalitis Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Encephalitis Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Encephalitis Vaccine Sales, 2017-2028
  6.8.3 Turkey Encephalitis Vaccine Market Size, 2017-2028
  6.8.4 Israel Encephalitis Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Encephalitis Vaccine Market Size, 2017-2028
  6.8.6 UAE Encephalitis Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Valneva
  7.1.1 Valneva Corporate Summary
  7.1.2 Valneva Business Overview
  7.1.3 Valneva Encephalitis Vaccine Major Product Offerings
  7.1.4 Valneva Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Valneva Key News
7.2 Sanofi Pasteur
  7.2.1 Sanofi Pasteur Corporate Summary
  7.2.2 Sanofi Pasteur Business Overview
  7.2.3 Sanofi Pasteur Encephalitis Vaccine Major Product Offerings
  7.2.4 Sanofi Pasteur Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi Pasteur Key News
7.3 Biken
  7.3.1 Biken Corporate Summary
  7.3.2 Biken Business Overview
  7.3.3 Biken Encephalitis Vaccine Major Product Offerings
  7.3.4 Biken Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Biken Key News
7.4 Wuhan Institute of Biological Products
  7.4.1 Wuhan Institute of Biological Products Corporate Summary
  7.4.2 Wuhan Institute of Biological Products Business Overview
  7.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Major Product Offerings
  7.4.4 Wuhan Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Wuhan Institute of Biological Products Key News
7.5 Lanzhou Institute of Biological Products
  7.5.1 Lanzhou Institute of Biological Products Corporate Summary
  7.5.2 Lanzhou Institute of Biological Products Business Overview
  7.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Major Product Offerings
  7.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Lanzhou Institute of Biological Products Key News
7.6 Chengdu Institute of Biological Products
  7.6.1 Chengdu Institute of Biological Products Corporate Summary
  7.6.2 Chengdu Institute of Biological Products Business Overview
  7.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Major Product Offerings
  7.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Chengdu Institute of Biological Products Key News
7.7 Tiantan Biological Products
  7.7.1 Tiantan Biological Products Corporate Summary
  7.7.2 Tiantan Biological Products Business Overview
  7.7.3 Tiantan Biological Products Encephalitis Vaccine Major Product Offerings
  7.7.4 Tiantan Biological Products Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 Tiantan Biological Products Key News
7.8 Liaoning Chengda
  7.8.1 Liaoning Chengda Corporate Summary
  7.8.2 Liaoning Chengda Business Overview
  7.8.3 Liaoning Chengda Encephalitis Vaccine Major Product Offerings
  7.8.4 Liaoning Chengda Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 Liaoning Chengda Key News
7.9 Zhejiang Tianyuan Bio-Pharmaceutical
  7.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporate Summary
  7.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
  7.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Major Product Offerings
  7.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Key News
7.10 Yisheng Bio
  7.10.1 Yisheng Bio Corporate Summary
  7.10.2 Yisheng Bio Business Overview
  7.10.3 Yisheng Bio Encephalitis Vaccine Major Product Offerings
  7.10.4 Yisheng Bio Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.10.5 Yisheng Bio Key News
7.11 Changchun Institute of Biological Products
  7.11.1 Changchun Institute of Biological Products Corporate Summary
  7.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Business Overview
  7.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Major Product Offerings
  7.11.4 Changchun Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2017-2022)
  7.11.5 Changchun Institute of Biological Products Key News

8 GLOBAL ENCEPHALITIS VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Encephalitis Vaccine Production Capacity, 2017-2028
8.2 Encephalitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Encephalitis Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ENCEPHALITIS VACCINE SUPPLY CHAIN ANALYSIS

10.1 Encephalitis Vaccine Industry Value Chain
10.2 Encephalitis Vaccine Upstream Market
10.3 Encephalitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Encephalitis Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Encephalitis Vaccine in Global Market
Table 2. Top Encephalitis Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Encephalitis Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Encephalitis Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Encephalitis Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Encephalitis Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Encephalitis Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Encephalitis Vaccine Product Type
Table 9. List of Global Tier 1 Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Encephalitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Encephalitis Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Encephalitis Vaccine Sales (M Doses), 2023-2028
Table 16. By Application – Global Encephalitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Encephalitis Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Encephalitis Vaccine Sales (M Doses), 2023-2028
Table 21. By Region – Global Encephalitis Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Encephalitis Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Encephalitis Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Encephalitis Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Encephalitis Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Encephalitis Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Encephalitis Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Encephalitis Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Encephalitis Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Encephalitis Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Encephalitis Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Encephalitis Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Encephalitis Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Encephalitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Encephalitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Encephalitis Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Encephalitis Vaccine Sales, (M Doses), 2023-2028
Table 46. Valneva Corporate Summary
Table 47. Valneva Encephalitis Vaccine Product Offerings
Table 48. Valneva Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Sanofi Pasteur Corporate Summary
Table 50. Sanofi Pasteur Encephalitis Vaccine Product Offerings
Table 51. Sanofi Pasteur Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Biken Corporate Summary
Table 53. Biken Encephalitis Vaccine Product Offerings
Table 54. Biken Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Wuhan Institute of Biological Products Corporate Summary
Table 56. Wuhan Institute of Biological Products Encephalitis Vaccine Product Offerings
Table 57. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Lanzhou Institute of Biological Products Corporate Summary
Table 59. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Offerings
Table 60. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Chengdu Institute of Biological Products Corporate Summary
Table 62. Chengdu Institute of Biological Products Encephalitis Vaccine Product Offerings
Table 63. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Tiantan Biological Products Corporate Summary
Table 65. Tiantan Biological Products Encephalitis Vaccine Product Offerings
Table 66. Tiantan Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Liaoning Chengda Corporate Summary
Table 68. Liaoning Chengda Encephalitis Vaccine Product Offerings
Table 69. Liaoning Chengda Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Zhejiang Tianyuan Bio-Pharmaceutical Corporate Summary
Table 71. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Offerings
Table 72. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Yisheng Bio Corporate Summary
Table 74. Yisheng Bio Encephalitis Vaccine Product Offerings
Table 75. Yisheng Bio Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Changchun Institute of Biological Products Corporate Summary
Table 77. Changchun Institute of Biological Products Encephalitis Vaccine Product Offerings
Table 78. Changchun Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Encephalitis Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 80. Global Encephalitis Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Encephalitis Vaccine Production by Region, 2017-2022 (M Doses)
Table 82. Global Encephalitis Vaccine Production by Region, 2023-2028 (M Doses)
Table 83. Encephalitis Vaccine Market Opportunities & Trends in Global Market
Table 84. Encephalitis Vaccine Market Drivers in Global Market
Table 85. Encephalitis Vaccine Market Restraints in Global Market
Table 86. Encephalitis Vaccine Raw Materials
Table 87. Encephalitis Vaccine Raw Materials Suppliers in Global Market
Table 88. Typical Encephalitis Vaccine Downstream
Table 89. Encephalitis Vaccine Downstream Clients in Global Market
Table 90. Encephalitis Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Encephalitis Vaccine Segment by Type
Figure 2. Encephalitis Vaccine Segment by Application
Figure 3. Global Encephalitis Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Encephalitis Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Encephalitis Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Encephalitis Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Encephalitis Vaccine Revenue in 2021
Figure 9. By Type - Global Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Encephalitis Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Encephalitis Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 19. US Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 33. China Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Encephalitis Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Encephalitis Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Encephalitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Encephalitis Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Encephalitis Vaccine by Region, 2021 VS 2028
Figure 50. Encephalitis Vaccine Industry Value Chain
Figure 51. Marketing Channels